English
- +

PROCURAR POR


Contemporary use and effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention.

Nome dos autores:

Gurm HS1, Smith DE, Berwanger O, Share D, Schreiber T, Moscucci M, Nallamothu BK; BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium)

Publicado em: JACC Cardiovasc Interv. 2012 Jan;5(1):98-104. doi: 10.1016/j.jcin.2011.09.019.

Artigo: Clique aqui

Acetylcysteine for the Prevention of Renal Outcomes in Patients With Diabetes Mellitus Undergoing Coronary and Peripheral Vascular Angiography: A Substudy of the Acetylcysteine for Contrast-Induced Nephropathy Trial

Nome dos autores:

Berwanger O1Cavalcanti ABSousa AMBuehler ACastello-Júnior HJCantarelli MJMangione JABergo RRSão Thiago LENunes PMda Motta PA,Kodama AVictor ECarvalho VOSousa JEAcetylcysteine for Contrast-Induced Nephropathy Trial Investigators

Publicado em: Circ Cardiovasc Interv. 2013 Apr;6(2):139-45. doi: 10.1161/CIRCINTERVENTIONS.112.000149. Epub 2013 Apr 9.

Artigo: Clique aqui

Efficiency of Brazilian States and the Federal District in the public kidney transplant system based on DEA (Data Envelopment Analysis) and the Malmquist index

Nome dos autores:

Cassia Kely Favoretto Costa, Giácomo Balbinotto Neto, Luciano Menezes Bezerra Sampaio

Publicado em: Cad. Saúde Pública vol.30 no.8 Rio de Janeiro ago. 2014

Artigo: Clique aqui

Development and testing of a decision board to help clinicians present treatment options to lupus nephritis patients in Brazil

Nome dos autores: De Abreu MM, Gafni A, Ferraz MB.

Publicado em: Arthritis Rheum. 2009 Jan 15; 61 (1): 37-45.

Artigo: Clique aqui

1 2 > >>